Skip to main content

Want a detailed portfolio tracker?

Nautilus Biotechnology (NAUT) P/E (2021 - 2026)

Nautilus Biotechnology (NAUT) P/E from Jun 10, 2021 to Jun 3, 2026. The TTM Nautilus Biotechnology (NAUT) P/E is -5.72. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Nautilus Biotechnology (NAUT)

YearP/EChange
2026-5.72+37.00%
2025-4.18+40.07%
2024-2.98-52.06%
2023-6.22+69.81%
2022-3.66-58.14%
2021-8.75N/A

Comparison Nautilus Biotechnology (NAUT) P/E with competitors

Nautilus Biotechnology (NAUT) P/E is -5.72.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.10-101.79%
ENLVEnlivex Therapeutics Ltd0.15-102.63%
FGENFibroGen Inc0.24-104.20%
TRAWTraws Pharma Inc0.47-108.27%
FBIOFortress Biotech Inc0.71-112.34%
CHRSCoherus Biosciences Inc0.98-117.10%
ORMPOramed Pharmaceuticals Inc1.47-125.76%
AGENAgenus Inc2.05-135.81%
VIVSVivoSim Labs Inc2.54-144.33%
INVAInnoviva Inc3.19-155.74%
CRMDCorMedix Inc3.65-163.74%
ABEOAbeona Therapeutics Inc4.20-173.52%
VXRTVaxart Inc4.26-174.51%
CVACCureVac N.V.4.45-177.72%
SRPTSarepta Therapeutics Inc4.62-180.85%
GLPGGalapagos NV4.86-184.95%
RIGLRigel Pharmaceuticals4.92-186.01%
ZVRAZevra Therapeutics Inc4.97-186.96%
ABUSArbutus Biopharma Corp5.69-199.55%
CGENCompugen Ltd7.38-229.10%
AUPHAurinia Pharmaceuticals Inc9.25-261.75%
ACADAcadia Pharmaceuticals Inc9.59-267.63%
OMEROmeros Corporation9.88-272.80%
PLXProtalix BioTherapeutics Inc9.91-273.25%
SPROSpero Therapeutics Inc10.73-287.68%
ADMAAdma Biologics Inc11.33-298.10%
SVASinovac Biotech Ltd11.44-299.94%
TBPHTheravance Biopharma Inc11.78-305.90%
HRMYHarmony Biosciences Holdings Inc12.18-312.96%
TGTXTG Therapeutics Inc13.18-330.42%
INCYIncyte Corp13.38-333.96%
SABSSAB Biotherapeutics Inc14.06-345.78%
XOMAXOMA Corp14.95-361.30%
REGNRegeneron Pharmaceuticals Inc14.98-361.91%
PBYIPuma Biotechnology Inc15.05-363.13%
EXELExelixis Inc15.79-376.15%
CPRXCatalyst Pharmaceuticals Inc17.34-403.25%
MDXGMimedx Group Inc17.38-403.78%
ARGXArgen X SE23.07-503.37%
HALOHalozyme Therapeutics Inc23.20-505.63%
XOMAOXOMA Corp25.34-543.12%
VRTXVertex Pharmaceuticals Inc25.66-548.55%
XOMAPXOMA Corp25.67-548.80%
CTMXCytomX Therapeutics Inc25.70-549.29%
ASNDAscendis Pharma A/S26.35-560.76%
RPRXRoyalty Pharma plc - Class A27.50-580.72%
SLNOSoleno Therapeutics Inc29.02-607.29%
LGNDLigand Pharmaceuticals Inc - Class B30.19-627.77%
BMRNBiomarin Pharmaceutical Inc37.51-755.76%
APLSApellis Pharmaceuticals Inc39.02-782.23%
KRYSKrystal Biotech Inc39.70-794.05%
GMABGenmab40.20-802.90%
ONCBeiGene Ltd67.03-1271.87%
TECHBio-Techne Corp68.59-1299.29%
VCELVericel Corp80.63-1509.69%
PHARPharming Group N.V.87.74-1634.01%
ALNYAlnylam Pharmaceuticals Inc124.93-2284.29%
TLXTelix Pharmaceuticals Ltd139.89-2545.79%
CORTCorcept Therapeutics Inc158.39-2869.21%